Hot or Not, Stock Market Edition: 04/14/2026

By Jessie Moore, Stock Researcher and Writer
April 14, 2026 5:09 AM UTC
Hot or Not, Stock Market Edition: 04/14/2026

Happy Tuesday. Here are the stock stories we're following today:

  • Applied Industrial Technologies (AIT) enjoys a mighty tailwind; hubba-hubba action for HubSpot (HUBS)
  • Why investors should avoid CervoMed (CRVO) despite an exciting pop; Wolfspeed (WOLF) proves that not all semiconductor stocks are hot right now.

P.S. Speaking of hot, did you see our guide to the 4 hottest stocks in the 4 hottest sectors right now? Get it here.


A note from our sponsors...

Buffett's $114 Secret In 1943, a teenage Warren Buffett put $114 into a special type of account called "The 29% Account." Today, that single, $114 investment would be worth over $15 million. Your bank never told you about this. Click Here to See How It Works

🔥 HOT: Industrial distribution stalwart Applied Industrial Technologies (AIT) may not be  a sexy stock, but it just got an alluring upgrade from C (Hold) to B (Buy) in our Zen Ratings system. The stock is up a respectable 7% in the past week and 30% in the past year, and has ticked past its 10-day moving average, prompting us to take a closer look. AIT appears to be benefiting from easing energy costs after the U.S.-Iran ceasefire deal; lower energy costs can improve margins for industrial distributors, and Trump's social media post signaling a de-escalation of Middle East conflict reduced supply chain concerns. AIT isn’t the only potential winner, of course; the broader industrial sector is trading higher amid overall market strength and reduced geopolitical risk. We already mentioned the Zen Rating upgrade, but what can we learn from the Component Grades that shape the overall rating? It earns excellent A Grades for Financials and Safety — a winning combo for risk-averse investors. TL;DR? With strong fundamentals, favorable macro conditions, and momentum on its side, AIT looks well-positioned for continued gains.

🥶 NOT: Biotech player CervoMed (CRVO) had a nice little 29% pop last week following a clinical update, but the stock has already dropped again. Is this a dip buy opportunity? Not so much. The fundamentals tell a grimmer story than one positive day suggests. The stock has a Zen Rating of F (Strong Sell), ranking 459 out of 460 stocks in the Biotech industry — nearly the worst stock in one of our worst Industries (Biotech industry rating: F). In addition to the dismal rating, it has dismal Component Grades: F Grades for Financials, Safety, and Value, plus D Grades for AI, Growth, Momentum, and Sentiment. The bottom line? Avoid this one like the plague. One-day pops on clinical program updates don't change the underlying reality: CervoMed ranks in the bottom 1% of all stocks for a reason, and investors would be wise to wait for sustained evidence of a turnaround before considering entry. 

🔥 HOT: CRM software leader HubSpot (HUBS) appears positioned for a breakout following its recent upgrade to Strong Buy. The broader tech sector is rallying —  recent Trump policy moves threw a lifeline to tech stocks, with the Nasdaq 100 targeting its eighth consecutive green day. HubSpot could ride this wave higher. Additionally, analysts are staying bullish despite market volatility, citing now as the time to buy the dip on stocks like HUBS. The stock was recently upgraded to a Zen Rating of A or Strong Buy, meaning it currently ranks in the top 5% of stocks based on a 115-factor review. Looking at the Component Grades, it scores particularly well with an A Grade for Growth and a B Grade for Financials and from our proprietary AI factor. The verdict? This looks like a compelling entry point for a high-quality software name trading at a discount, especially if the tech rally has legs.

🥶 NOT: Wolfspeed (WOLF) has the dubious honor of proving that not all semiconductor stocks are hot right now. Despite a significant 30% gain last week following recent positive news flow including mentions in articles about BlackBerry's strong Q4 and industry reports on gallium arsenide wafers poised for Q2 price surges, our Zen Ratings tell a more dire tale. WOLF earns an overall F (Strong Sell) rating, placing it in the bottom tier of stocks we track. Looking at the Component Grades, it disappoints across the board with D Grades for AI, Financials, Safety, and Value, and ranks 64th out of 66 companies in the Semiconductor industry. The verdict? Despite operating in a B-rated industry and some positive news catalysts around materials pricing, Wolfspeed's abysmal fundamentals suggest there are better semiconductor stocks out there. (Like THESE.)

What to Do Next?

Want to get in touch? Email us at news@wallstreetzen.com.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.